---
figid: PMC138693__bcr312-2
figtitle: Phosphoinositide 3-kinase (PI3K) signalling and cancer
organisms:
- NA
pmcid: PMC138693
filename: bcr312-2.jpg
figlink: /pmc/articles/PMC138693/figure/F2/
number: F2
caption: Phosphoinositide 3-kinase (PI3K) signalling and cancer. Schematic signalling
  pathway indicating the interactions that occur between known breast cancer oncogenes
  (ErbB2, Src) and tumour suppressors (PTEN, BRCA1) with components of the PI3K signalling
  cassette. Direct physical interactions are shown with solid arrows. Processes involving
  several steps are indicated with a dashed arrow; +, an activation step. Blunt arrows
  indicate inhibitory effects. Akt, Protein kinase B; ATM, ataxia telangiectasia mutated;
  ER, oestrogen receptor; 3-Ptase and 5-Ptase, phosphoinositide 3-phosphatase and
  phosphoinositide 5-phosphatase activities; PTEN, phosphatase and tensin homolog
  deleted on chromosome 10; TOR, target of rapamycin.
papertitle: 'Phosphoinositide 3-kinase signalling in breast cancer: how big a role
  might it play?.'
reftext: Michael John Fry. Breast Cancer Res. 2001;3(5):304-312.
year: '2001'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9256951
figid_alias: PMC138693__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC138693__F2
ndex: 276b9e79-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC138693__bcr312-2.html
  '@type': Dataset
  description: Phosphoinositide 3-kinase (PI3K) signalling and cancer. Schematic signalling
    pathway indicating the interactions that occur between known breast cancer oncogenes
    (ErbB2, Src) and tumour suppressors (PTEN, BRCA1) with components of the PI3K
    signalling cassette. Direct physical interactions are shown with solid arrows.
    Processes involving several steps are indicated with a dashed arrow; +, an activation
    step. Blunt arrows indicate inhibitory effects. Akt, Protein kinase B; ATM, ataxia
    telangiectasia mutated; ER, oestrogen receptor; 3-Ptase and 5-Ptase, phosphoinositide
    3-phosphatase and phosphoinositide 5-phosphatase activities; PTEN, phosphatase
    and tensin homolog deleted on chromosome 10; TOR, target of rapamycin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - brk
  - Src64B
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Myb
  - Taf5
  - Pten
  - Cyp4p2
  - fab1
  - Pdk1
  - Akt
  - tor
  - Tor
  - Egfr
  - CycD
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CycE
  - cyc
  - tefu
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - PTK6
  - SRC
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PTEN
  - INPP5A
  - INPP5B
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - RORC
  - BRCA1
  - CCND1
  - CCND2
  - CCND3
  - ATM
  - Ly294002
  - Rapamycin
  - Cancer
  - Lung cancer
---
